Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centred, Randomised, Double-blind, Two Arms, Parallel Group, Placebo-controlled Study to Assess the Effect of Compound Sodium Alginate Oral Suspension Sachet in Patients With Reflux Disease

NCT02623062 is registered in ClinicalTrials.gov with Reckitt Benckiser Healthcare (UK) Limited as lead sponsor.

NCT NCT02623062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02623062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centred, Randomised, Double-blind, Two Arms, Parallel Group, Placebo-controlled Study to Assess the Effect of Compound Sodium Alginate Oral Suspension Sachet in Patients With Reflux Disease
Lead sponsor
Reckitt Benckiser Healthcare (UK) Limited
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2013
Completion date
May 31, 2016
Enrollment
644 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastro-esophageal reflux disease (gerd)